News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,371 Results
Type
Article (41230)
Company Profile (258)
Press Release (666883)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205790)
Career Advice (2062)
Deals (35619)
Drug Delivery (97)
Drug Development (82043)
Employer Resources (172)
FDA (16476)
Job Trends (15025)
News (348684)
Policy (33193)
Tag
Academia (2621)
Accelerated approval (5)
Adcomms (22)
Allergies (86)
Alliances (50033)
ALS (94)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (137)
Approvals (16469)
Artificial intelligence (271)
Autoimmune disease (22)
Automation (16)
Bankruptcy (361)
Best Places to Work (11775)
BIOSECURE Act (19)
Biosimilars (109)
Biotechnology (182)
Bladder cancer (81)
Brain cancer (29)
Breast cancer (297)
Cancer (2346)
Cardiovascular disease (183)
Career advice (1724)
Career pathing (30)
CAR-T (157)
Cell therapy (443)
Cervical cancer (20)
Clinical research (66865)
Collaboration (867)
Company closure (2)
Compensation (557)
Complete response letters (20)
COVID-19 (2629)
CRISPR (42)
C-suite (253)
Cystic fibrosis (102)
Data (2311)
Decentralized trials (2)
Denatured (20)
Depression (45)
Diabetes (276)
Diagnostics (6495)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87340)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (113790)
Executive appointments (748)
FDA (17855)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (771)
Gene editing (111)
Generative AI (21)
Gene therapy (318)
GLP-1 (729)
Government (4506)
Grass and pollen (4)
Guidances (150)
Healthcare (19145)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (127)
Indications (30)
Infectious disease (2777)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (329)
IPO (16582)
IRA (40)
Job creations (3657)
Job search strategy (1459)
Kidney cancer (10)
Labor market (43)
Layoffs (477)
Leadership (17)
Legal (7986)
Liver cancer (78)
Lung cancer (330)
Lymphoma (156)
Machine learning (9)
Management (58)
Manufacturing (329)
MASH (74)
Medical device (13617)
Medtech (13622)
Mergers & acquisitions (19610)
Metabolic disorders (708)
Multiple sclerosis (82)
NASH (17)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1947)
NextGen: Class of 2025 (6622)
Non-profit (4541)
Now hiring (40)
Obesity (375)
Opinion (212)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (89)
Parkinson's disease (151)
Partnered (21)
Patents (244)
Patient recruitment (116)
Peanut (46)
People (57810)
Pharmaceutical (65)
Pharmacy benefit managers (19)
Phase I (20772)
Phase II (29438)
Phase III (21972)
Pipeline (1350)
Policy (146)
Postmarket research (2624)
Preclinical (8826)
Press Release (66)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (248)
Rare diseases (387)
Real estate (5976)
Recruiting (65)
Regulatory (22858)
Reports (47)
Research institute (2382)
Resumes & cover letters (353)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (134)
Series B (88)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (149)
Sponsored (30)
Startups (3614)
State (2)
Stomach cancer (15)
Supply chain (68)
Tariffs (48)
The Weekly (30)
Vaccines (709)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Last 7 days (932)
Last 30 days (3005)
Last 365 days (32651)
2025 (11765)
2024 (35600)
2023 (40479)
2022 (51579)
2021 (56116)
2020 (54607)
2019 (47270)
2018 (35586)
2017 (32572)
2016 (31982)
2015 (38003)
2014 (31693)
2013 (26729)
2012 (28994)
2011 (29704)
2010 (27770)
Location
Africa (735)
Alabama (54)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (38532)
Australia (6322)
California (6406)
Canada (2065)
China (536)
Colorado (273)
Connecticut (280)
Delaware (157)
Europe (83809)
Florida (951)
Georgia (212)
Idaho (57)
Illinois (549)
India (26)
Indiana (321)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (929)
Massachusetts (4778)
Michigan (224)
Minnesota (406)
Mississippi (2)
Missouri (82)
Montana (28)
Nebraska (25)
Nevada (68)
New Hampshire (65)
New Jersey (1799)
New Mexico (29)
New York (1814)
North Carolina (1005)
North Dakota (9)
Northern California (2810)
Ohio (211)
Oklahoma (15)
Oregon (34)
Pennsylvania (1423)
Puerto Rico (13)
Rhode Island (33)
South America (1112)
South Carolina (25)
South Dakota (1)
Southern California (2413)
Tennessee (105)
Texas (949)
United States (24063)
Utah (190)
Virginia (153)
Washington D.C. (65)
Washington State (567)
West Virginia (3)
Wisconsin (56)
708,371 Results for "standard bariatrics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
April 30, 2025
·
8 min read
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Standard BioTools Reports First Quarter 2025 Financial Results
May 7, 2025
·
16 min read
Press Releases
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards
December 16, 2024
·
2 min read
Press Releases
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
April 23, 2025
·
1 min read
Press Releases
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
April 29, 2025
·
6 min read
Press Releases
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
April 24, 2025
·
4 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
Deals
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2024
Standard BioTools Inc. today announced that the Human Capital Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 20, 2024, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan).
May 20, 2024
·
2 min read
Press Releases
Travere Therapeutics and CSL Vifor Announce Standard EU Approval of FILSPARI® (sparsentan) for IgA Nephropathy
April 29, 2025
·
18 min read
1 of 70,838
Next
